A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk.
Saved in:
| Title: | A Model‐Informed Drug Development Approach to Design a Phase 3 Trial of Teverelix Drug Product in Advanced Prostate Cancer Patients with Increased Cardiovascular Risk. |
|---|---|
| Authors: | Sannala, Chenna Keshava Reddy1 (AUTHOR), MacLean, Carol2 (AUTHOR) cmaclean@antev.co.uk, Larsen, Finn2 (AUTHOR), van Os, Steve2 (AUTHOR), Jadhav, Pravin3 (AUTHOR), Shore, Neal4 (AUTHOR), Morgans, Alicia K.5 (AUTHOR), Okwuosa, Tochukwu6 (AUTHOR), Gobburu, Joga1 (AUTHOR) |
| Source: | Clinical Pharmacology in Drug Development. Aug2024, Vol. 13 Issue 8, p915-929. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2160763X |
|---|---|
| DOI: | 10.1002/cpdd.1415 |
